Bioinformatics-based prediction of conformational epitopes for Enterovirus A71 and Coxsackievirus A16 | Scientific Reports
Manassantin B shows antiviral activity against coxsackievirus B3 infection by activation of the STING/TBK-1/IRF3 signalling pathway | Scientific Reports
Cum se manifestă infecţia cu virusurile Coxsackie
Type B coxsackieviruses and their interactions with the innate and adaptive immune systems | Future Microbiology
Manassantin B shows antiviral activity against coxsackievirus B3 infection by activation of the STING/TBK-1/IRF3 signalling pathway | Scientific Reports
Coxsackievirus B3 replication and pathogenesis | Future Microbiology
Microorganisms | Free Full-Text | Persistence of Coxsackievirus B4 in Pancreatic β Cells Disturbs Insulin Maturation, Pattern of Cellular Proteins, and DNA Methylation | HTML
Alternatively Spliced Soluble Coxsackie-adenovirus Receptors Inhibit Coxsackievirus Infection* - Journal of Biological Chemistry
A Short History and Introductory Background on the Coxsackieviruses of Group B | SpringerLink
Coxsackie B4 virus infection of β cells and natural killer cell insulitis in recent-onset type 1 diabetic patients | PNAS
Le virus coxsakie et le déclenchement du diabète de type 1 ? — Site des ressources d'ACCES pour enseigner les Sciences de la Vie et de la Terre
Antiviral Activity of Oroxylin A against Coxsackievirus B3 Alleviates Virus-Induced Acute Pancreatic Damage in Mice | PLOS ONE
PDF) Hand-foot-and-mouth disease virus receptor KREMEN1 binds the canyon of Coxsackie Virus A10
Persistent coxsackievirus B1 infection triggers extensive changes in the transcriptome of human pancreatic ductal cells - ScienceDirect
A hexavalent Coxsackievirus B vaccine is highly immunogenic and has a strong protective capacity in mice and nonhuman primates | Science Advances
AC. ANTI COXSACKIE A VIRUS (A2,4,7,9,10,16) – laboratorios
Enterovirus 71 and Coxsackievirus A16 3C Proteases: Binding to Rupintrivir and Their Substrates and Anti-Hand, Foot, and Mouth Disease Virus Drug Design | Journal of Virology
Cryo-EM structures reveal the molecular basis of receptor-initiated coxsackievirus uncoating - ScienceDirect
Coxsackie Virus RT-PCR
Experimental autoimmune myocarditis versus coxsackievirus B3 induced... | Download Scientific Diagram
Coxsackievirus Type B3 Is a Potent Oncolytic Virus against KRAS-Mutant Lung Adenocarcinoma: Molecular Therapy - Oncolytics
Enterovirus 71 and Coxsackievirus A16 3C Proteases: Binding to Rupintrivir and Their Substrates and Anti-Hand, Foot, and Mouth Disease Virus Drug Design | Journal of Virology
Molecular basis of Coxsackievirus A10 entry using the two-in-one attachment and uncoating receptor KRM1 | PNAS
Molecular basis of Coxsackievirus A10 entry using the two-in-one attachment and uncoating receptor KRM1 | PNAS
MicroRNA Modification of Coxsackievirus B3 Decreases Its Toxicity, while Retaining Oncolytic Potency against Lung Cancer: Molecular Therapy - Oncolytics
A Common Virus May Be Linked to Heart Problems in Fetuses | Live Science
Frontiers | Neonatal Murine Model of Coxsackievirus A2 Infection for the Evaluation of Antiviral Therapeutics and Vaccination
